Inhibition of theophylline clearance by cimetidine but not ranitidine

J. R. Powell, J. F. Rogers, W. A. Wargin, R. E. Cross, F. N. Eshelman

Research output: Contribution to journalArticle

Abstract

This study was designed to compare the effects of equivalent therapeutic doses of two H2 antagonists, cimetidine and ranitidine, on theophylline pharmacokinetics and to determine whether the previously described cimetidine-theophylline interaction is dose dependent. Twelve healthy adult men were given a 6-mg/kg intravenous aminophylline dose on four occasions. Subjects were randomly assigned four treatments: no treatment (control); cimetidine, 1,200 mg/day; cimetidine, 2,400 mg/day; and ranitidine, 300 mg/day. Cimetidine, 1,200 mg/day, significantly decreased theophylline clearance by 36% (range, 22% to 49%) and increased the mean elimination half-life from 5.7 hours (control) to 9.2 hours. A significant difference was not found between the two cimetidine dosages, indicating dose independence of the interaction over the dosage range studied. Ranitidine did not significantly alter theophylline pharmacokinetics. Theophylline plasma protein binding was not affected by any treatment. The relative effects of cimetidine and ranitidine on the elimination of cytochrome P-450 metabolized drugs such as theophylline indicate a useful property of ranitidine as compared with cimetidine.

Original languageEnglish (US)
Pages (from-to)484-486
Number of pages3
JournalArchives of Internal Medicine
Volume144
Issue number3
DOIs
StatePublished - 1984
Externally publishedYes

Fingerprint

Ranitidine
Cimetidine
Theophylline
Pharmacokinetics
Aminophylline
Therapeutic Uses
Protein Binding
Cytochrome P-450 Enzyme System
Half-Life
Blood Proteins
Therapeutics

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Powell, J. R., Rogers, J. F., Wargin, W. A., Cross, R. E., & Eshelman, F. N. (1984). Inhibition of theophylline clearance by cimetidine but not ranitidine. Archives of Internal Medicine, 144(3), 484-486. https://doi.org/10.1001/archinte.144.3.484

Inhibition of theophylline clearance by cimetidine but not ranitidine. / Powell, J. R.; Rogers, J. F.; Wargin, W. A.; Cross, R. E.; Eshelman, F. N.

In: Archives of Internal Medicine, Vol. 144, No. 3, 1984, p. 484-486.

Research output: Contribution to journalArticle

Powell, JR, Rogers, JF, Wargin, WA, Cross, RE & Eshelman, FN 1984, 'Inhibition of theophylline clearance by cimetidine but not ranitidine', Archives of Internal Medicine, vol. 144, no. 3, pp. 484-486. https://doi.org/10.1001/archinte.144.3.484
Powell, J. R. ; Rogers, J. F. ; Wargin, W. A. ; Cross, R. E. ; Eshelman, F. N. / Inhibition of theophylline clearance by cimetidine but not ranitidine. In: Archives of Internal Medicine. 1984 ; Vol. 144, No. 3. pp. 484-486.
@article{80559dc6b165449b8d011b4ac2de01d5,
title = "Inhibition of theophylline clearance by cimetidine but not ranitidine",
abstract = "This study was designed to compare the effects of equivalent therapeutic doses of two H2 antagonists, cimetidine and ranitidine, on theophylline pharmacokinetics and to determine whether the previously described cimetidine-theophylline interaction is dose dependent. Twelve healthy adult men were given a 6-mg/kg intravenous aminophylline dose on four occasions. Subjects were randomly assigned four treatments: no treatment (control); cimetidine, 1,200 mg/day; cimetidine, 2,400 mg/day; and ranitidine, 300 mg/day. Cimetidine, 1,200 mg/day, significantly decreased theophylline clearance by 36{\%} (range, 22{\%} to 49{\%}) and increased the mean elimination half-life from 5.7 hours (control) to 9.2 hours. A significant difference was not found between the two cimetidine dosages, indicating dose independence of the interaction over the dosage range studied. Ranitidine did not significantly alter theophylline pharmacokinetics. Theophylline plasma protein binding was not affected by any treatment. The relative effects of cimetidine and ranitidine on the elimination of cytochrome P-450 metabolized drugs such as theophylline indicate a useful property of ranitidine as compared with cimetidine.",
author = "Powell, {J. R.} and Rogers, {J. F.} and Wargin, {W. A.} and Cross, {R. E.} and Eshelman, {F. N.}",
year = "1984",
doi = "10.1001/archinte.144.3.484",
language = "English (US)",
volume = "144",
pages = "484--486",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "3",

}

TY - JOUR

T1 - Inhibition of theophylline clearance by cimetidine but not ranitidine

AU - Powell, J. R.

AU - Rogers, J. F.

AU - Wargin, W. A.

AU - Cross, R. E.

AU - Eshelman, F. N.

PY - 1984

Y1 - 1984

N2 - This study was designed to compare the effects of equivalent therapeutic doses of two H2 antagonists, cimetidine and ranitidine, on theophylline pharmacokinetics and to determine whether the previously described cimetidine-theophylline interaction is dose dependent. Twelve healthy adult men were given a 6-mg/kg intravenous aminophylline dose on four occasions. Subjects were randomly assigned four treatments: no treatment (control); cimetidine, 1,200 mg/day; cimetidine, 2,400 mg/day; and ranitidine, 300 mg/day. Cimetidine, 1,200 mg/day, significantly decreased theophylline clearance by 36% (range, 22% to 49%) and increased the mean elimination half-life from 5.7 hours (control) to 9.2 hours. A significant difference was not found between the two cimetidine dosages, indicating dose independence of the interaction over the dosage range studied. Ranitidine did not significantly alter theophylline pharmacokinetics. Theophylline plasma protein binding was not affected by any treatment. The relative effects of cimetidine and ranitidine on the elimination of cytochrome P-450 metabolized drugs such as theophylline indicate a useful property of ranitidine as compared with cimetidine.

AB - This study was designed to compare the effects of equivalent therapeutic doses of two H2 antagonists, cimetidine and ranitidine, on theophylline pharmacokinetics and to determine whether the previously described cimetidine-theophylline interaction is dose dependent. Twelve healthy adult men were given a 6-mg/kg intravenous aminophylline dose on four occasions. Subjects were randomly assigned four treatments: no treatment (control); cimetidine, 1,200 mg/day; cimetidine, 2,400 mg/day; and ranitidine, 300 mg/day. Cimetidine, 1,200 mg/day, significantly decreased theophylline clearance by 36% (range, 22% to 49%) and increased the mean elimination half-life from 5.7 hours (control) to 9.2 hours. A significant difference was not found between the two cimetidine dosages, indicating dose independence of the interaction over the dosage range studied. Ranitidine did not significantly alter theophylline pharmacokinetics. Theophylline plasma protein binding was not affected by any treatment. The relative effects of cimetidine and ranitidine on the elimination of cytochrome P-450 metabolized drugs such as theophylline indicate a useful property of ranitidine as compared with cimetidine.

UR - http://www.scopus.com/inward/record.url?scp=0021367569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021367569&partnerID=8YFLogxK

U2 - 10.1001/archinte.144.3.484

DO - 10.1001/archinte.144.3.484

M3 - Article

C2 - 6322709

VL - 144

SP - 484

EP - 486

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 3

ER -